| Authors: |
Gilligan T; Taussig Cancer Institute and Institute and the Center for Excellence in Healthcare Communication, Cleveland Clinic, Cleveland, OH., Bohlke K; American Society of Clinical Oncology, Alexandria, VA., Alpert AB; Yale Cancer Center, Yale School of Medicine, New Haven, CT., Coyle N; Memorial Sloan Kettering Cancer Center, New York, NY., Harichand-Herdt S; Mission Blood + Cancer, Des Moines, IA., Lathan CS; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Razis E; 3rd Oncology Department, Hygeia Hospital, Athens, Greece., Rivera K; Oncology Nursing Society, Pittsburgh, PA., Sanft T; Yale Cancer Center, Smilow Cancer Hospital, Yale School of Medicine, New Haven, CT., Seigel C; Advocacy Representative, Brookline, MA., Times M; MetroHealth, Cleveland, OH., Chou CL; UCSF, Veterans Affairs Health Care System, San Francisco, CA. |
